125 / 1084
Oesophageal Cancer – CROSS Study
© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick
Shapiro J et al.,
Lancet Oncol
2015; 16: 1090–98
Median follow-up for surviving patients: 84·1 months
(HR 0·68 [95% CI 0·53–0·88]; log-rank p=0·003)